Literature DB >> 20107179

Rose bengal staining of the temporal conjunctiva differentiates Sjögren's syndrome from keratoconjunctivitis sicca.

Barbara Caffery1, Trefford Simpson, Sunny Wang, Denis Bailey, John McComb, John Rutka, Allan Slomovic, Arthur Bookman.   

Abstract

PURPOSE: To compare the clinical presentation of 231 patients with primary Sjögren's syndrome (pSS) with 89 patients with aqueous-deficient dry eye (keratoconjunctivitis sicca; KCS), to determine those procedures that best differentiate these groups in the eye care clinic.
METHODS: The records of all patients seen at the University Health Network Sjögren's Syndrome Clinic from October 1992 to July 2006 were reviewed and documented. The diagnosis of pSS was based on the AECC (American European Consensus Criteria) of 2002. KCS control subjects were non-SS patients with symptoms of dry eye and Schirmer scores of <or=10 mm in 5 minutes in at least one eye. There were 90 variables used in the analysis of the total database. Recursive partitioning was used to generate tree diagrams that demonstrated which characteristics best distinguished pSS from KCS.
RESULTS: Recursive partitioning of the full database demonstrated that the serum immunoglobulin Ro and the status of the salivary gland biopsy were most important in distinguishing pSS and KCS. The presence of rose bengal staining of the temporal conjunctiva was the most important noninvasive ocular variable that separated the groups. Total rose bengal staining also improved sensitivity. When only noninvasive techniques were used, staining of the temporal conjunctiva and severity of dry mouth symptoms were the major factors in distinguishing pSS from KCS.
CONCLUSIONS: Rose bengal staining of the ocular surface is an important observation in the detection of SS and the differentiation of pSS and KCS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20107179     DOI: 10.1167/iovs.09-4188

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  7 in total

1.  The increase of aqueous tear volume by diquafosol sodium in dry-eye patients with Sjögren's syndrome: a pilot study.

Authors:  N Yokoi; H Kato; S Kinoshita
Journal:  Eye (Lond)       Date:  2016-04-08       Impact factor: 3.775

2.  Association of Dry Eye Tests With Extraocular Signs Among 3514 Participants in the Sjögren's Syndrome International Registry.

Authors:  Vatinee Y Bunya; Satasuk Joy Bhosai; Ana Maria Heidenreich; Kazuko Kitagawa; Genevieve B Larkin; Thomas M Lietman; Bruce D Gaynor; Esen K Akpek; Mina Massaro-Giordano; M Srinivasan; Travis C Porco; John P Whitcher; Stephen C Shiboski; Lindsey A Criswell; Caroline H Shiboski
Journal:  Am J Ophthalmol       Date:  2016-09-16       Impact factor: 5.258

3.  Three percent diquafosol ophthalmic solution as an additional therapy to existing artificial tears with steroids for dry-eye patients with Sjögren's syndrome.

Authors:  N Yokoi; Y Sonomura; H Kato; A Komuro; S Kinoshita
Journal:  Eye (Lond)       Date:  2015-07-10       Impact factor: 3.775

4.  MUC1 expression in Sjogren's syndrome, KCS, and control subjects.

Authors:  Barbary Caffery; Miriam L Heynen; Elizabeth Joyce; Lyndon Jones; Robert Ritter; Michelle Senchyna
Journal:  Mol Vis       Date:  2010-08-24       Impact factor: 2.367

Review 5.  Current Approach to Dry Eye Disease.

Authors:  Valéria Valim; Virginia Fernandes Moça Trevisani; Jacqueline Martins de Sousa; Verônica Silva Vilela; Rubens Belfort
Journal:  Clin Rev Allergy Immunol       Date:  2015-12       Impact factor: 8.667

Review 6.  Optic neuritis as an initial presentation of primary Sjögren syndrome: A case report and literature review.

Authors:  Jia-Yue Sun; Zheng Liu; Peng Zhao; Tao Liu
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

Review 7.  Dry Eye Disease in Routine Rheumatology Practice.

Authors:  Sevastiani Ziaragkali; Aggeliki Kotsalidou; Nikolaos Trakos
Journal:  Mediterr J Rheumatol       Date:  2018-09-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.